Evidence map›Paper›PMID 30271139›Full record

ArticleInternational journal of nanomedicine2018

3D-printed scaffolds of mesoporous bioglass/gliadin/polycaprolactone ternary composite for enhancement of compressive strength, degradability, cell responses and new bone tissue ingrowth.

Yiqun Zhang, Wei Yu, Zhaoyu Ba, Shusen Cui, Jie Wei, Hong Li

Abstract read
In one paragraph

Article in International journal of nanomedicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. FeSInternational journal of bioprinting · 2023
    Article
  10. Review
  11. Review
  12. Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Yiqun ZhangDepartment of Hand Surgery, China-Japan Union Hospital, Jilin University, Changchun 130033, China, sscui916@126.com.
Wei YuDepartment of Hand Surgery, China-Japan Union Hospital, Jilin University, Changchun 130033, China, sscui916@126.com.
Zhaoyu BaDepartment of Spinal Surgery, Shanghai East Hospital, Tongji University School of Medicine, Shanghai 200120, China, greatspine@163.com.
Shusen CuiDepartment of Hand Surgery, China-Japan Union Hospital, Jilin University, Changchun 130033, China, sscui916@126.com.
Jie WeiKey Laboratory for Ultrafine Materials of Ministry of Education, East China University of Science and Technology, Shanghai 200237, China.
Hong LiCollege of Physical Science and Technology, Sichuan University, Chengdu 610041, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDue to the increasing number of patients with bone defects, bone nonunion and osteo-myelitis, tumor and congenital diseases, bone repair has become an urgent problem to be solved.

methodsIn this study, the 3D-printed scaffolds of ternary composites containing mesoporous bioglass fibers of magnesium calcium silicate (mMCS), gliadin (GA) and polycaprolactone (PCL) were fabricated using a 3D Bioprinter.

resultsThe compressive strength and in vitro degradability of the mMCS/GA/PCL composites (MGPC) scaffolds were improved with the increase of mMCS content. In addition, the attachment and proliferation of MC3T3-E1 cells on the scaffolds were significantly promoted with the increase of mMCS content. Moreover, the cells with normal phenotype attached and spread well on the scaffolds surfaces, indicating good cytocompatibility. The scaffolds were implanted into the femur defects of rabbits, and the results demonstrated that the scaffold containing mMCS stimulated new bone formation and ingrowth into the scaffolds through scaffolds degradation in vivo. Moreover, the expression of type I collagen into scaffolds was enhanced with the increase of mMCS content.

conclusionThe 3D-printed MGPC scaffold with controllable architecture, good biocompatibility, high compressive strength, proper degradability and excellent in vivo osteogenesis has great potential for bone regeneration.

Indexed as

Bone DevelopmentCompressive StrengthPrinting, Three-DimensionalAnimalsBiocompatible MaterialsBone and BonesBone RegenerationCalcium CompoundsCell AdhesionCell LineCell ProliferationCeramicsCollagen Type IFemaleFemurGliadinBiocompatible MaterialsBioglassCalcium Compoundscalcium silicateCollagen Type IFlorisilGliadinMagnesium SilicatespolycaprolactonePolyestersSilicatesSolutionsTromethaminebiocompatibilitycytocompatibilityosteogenesispolymer-based compositeternary composites

Identifiers

PMID30271139
PMCPMC6149932

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.